What GLP1 drugs are and why they work Glucagonlike peptide1 receptor agonists (GLP1 RAs) are medications that mimic the gut hormone GLP1, helping lower blood sugar and reduce appetite by enhancing glucosedependent insulin secretion and suppressing glucagon
The physiological landscape of Long COVID, ME/CFS, and related dysautonomias is heavily characterized by a profound, unyielding state of oxidative stress
High-fat and fried foods, heavily processed items, and alcohol can exacerbate common side effects such as nausea, bloating, and abdominal discomfort
Combining Tesamorelin and Ipamorelin can potentially offer synergistic effects, enhancing overall efficacy in GH stimulation with potentially fewer side effects than traditional GH therapy: While the combination of Tesamorelin and Ipamorelin can be beneficial, it also comes with potential risks and considerations: Research on both peptides, particularly on their combined use, is still emerging: The combination of Tesamorelin and Ipamorelin represents a promising approach to managing growth hormone levels, offering benefits like reduced abdominal fat, increased muscle mass, and improved recovery, while potentially minimizing the side effects associated with conventional GH therapies